跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
COMBINEB ( Nebuliser Solution Unit Dose Vial Ipratropium Bromide 0.5 mg and Salbutamol 2.5 mg ) - NPRA Drug Approval Details
Approvals
/
NPRA
/
COMBINEB ( Nebuliser Solution Unit Dose Vial Ipratropium Bromide 0.5 mg and Salbutamol 2.5 mg )
Approved
STANDARD
COMBINEB ( Nebuliser Solution Unit Dose Vial Ipratropium Bromide 0.5 mg and Salbutamol 2.5 mg )
AIN MEDICARE SDN. BHD.
🇲🇾 National Pharmaceutical Regulatory Agency
Approval Date
Nov 28, 2025
Approval ID
c562a95883803e16
Company
AIN MEDICARE SDN. BHD.
Type
Standard
Approval Details
Approval Id
c562a95883803e16
Drug Approval Npra Name
COMBINEB ( Nebuliser Solution Unit Dose Vial Ipratropium Bromide 0.5 mg and Salbutamol 2.5 mg )
Product Name
COMBINEB ( Nebuliser Solution Unit Dose Vial Ipratropium Bromide 0.5 mg and Salbutamol 2.5 mg )
Registration Number
MAL12115059AZ
Holder Company Name
AIN MEDICARE SDN. BHD.
Holder Address
LOT 4933, 4934 & PT2464, JALAN 6/44, KAW. PERINDUSTRIAN PENGKALAN CHEPA 2, 16100 KOTA BHARU MALAYSIA
Holder Phone
09-7743388
Manufacturer Company Name
AIN MEDICARE SDN. BHD.
Manufacturer Address
LOT 4933, 4934 & PT2464, JALAN 6/44 KAWASAN PERINDUSTRIAN PENGKALAN CHEPA 2 16100 KOTA BHARU MALAYSIA
Source Url
https://quest3plus.bpfk.gov.my/pmo2/detail.php?type=product&id=MAL12115059AZ
Version
1751614623
Active Ingredients
Approved
Quick Info
Agency
NPRA
Country
🇲🇾
Approval Date
Nov 28, 2025
Approval ID
c562a95883803e16
Type
Standard
Source
Official Source
Back to NPRA Approvals